Biphasic Mesothelioma

Mesothelioma is a rare, deadly cancer caused by exposure to asbestos. Patients receive a diagnosis of biphasic mesothelioma when their tumors include a mixture of two cell types, called sarcomatoid and epithelioid.

If you or a loved one were diagnosed with mesothelioma, asbestos-related lung cancer, or asbestosis, you might be entitled to substantial compensation. We invite you to fill out our form today for a free Financial Compensation Packet, filled with information about experienced mesothelioma lawyers in your area, how to get paid in 90 days, how to file an asbestos trust fund claim, and much more. 

What Is Biphasic Mesothelioma?

Biphasic mesothelioma is the combination of two mesothelioma cell types: epithelioid and sarcomatoid. If you have a higher ratio of epithelioid cells, then the tumors do not spread as fast.

If you have a higher ratio of the sarcomatoid cell, the biphasic tumors spread much more quickly throughout the body.

Biphasic mesothelioma is the second most common type of diagnosed cell type of mesothelioma cancer, accounting for around 30% of all diagnoses.

How Is Biphasic Mesothelioma Diagnosed and Treated?

When diagnosing biphasic mesothelioma, doctors generally use immunohistochemistry, a medical technique that involves coating the cells with a colored dye so that cells are more easily identified. It also lets physicians know if cancer is actually present.

People with pleural mesothelioma are diagnosed with biphasic mesothelioma more than any other type of the disease. Therefore, treatment of biphasic mesothelioma is the same for pleural mesothelioma patients: surgery (if applicable, the patient must be in good overall health), chemotherapy, or radiation therapy.

A few new treatments for biphasic mesothelioma showed positive results during clinical trials. 

Intensity-modulated radiation therapy, gene therapy, and photodynamic therapy have positively affected patients with biphasic mesothelioma.

Long-Term Outlook For Patients With Biphasic Mesothelioma

As mentioned earlier, there are two different cell types in biphasic mesothelioma: epithelioid and sarcomatoid. The more dominant cell type will greatly influence the prognosis of biphasic mesothelioma patients.

Patients with more epithelioid cells generally have a better long-term outlook, whereas patients with more sarcomatoid cells have a poorer prognosis. The survival rate is about 12 months after diagnosis.

However, keep in mind that each case is different from the next as each patient has their own unique medical history. This means that many patients can go on to beat the odds of the average survival rate and live much longer by living a healthy, stress-free lifestyle.

The stage of cancer will also determine the long-term outlook. Patients in the earlier stages of cancer, stage I and Stage II, have a better chance of a prolonged survival rate.

Those in the later stages of cancer, Stage III and Stage IV, have a lower survival rate, but again, living a healthy lifestyle that includes a doctor-approved exercise plan, a nutritious diet, and living a life with minimum stress will go a long way in helping improve survival rates.

A diagnosis of biphasic mesothelioma can be confusing. Talk to your medical team about your diagnosis and any questions you have regarding cell type.

Additional Help and Information for Biphasic Mesothelioma Patients

If you’ve been injured by asbestos, keep in mind that there is a good chance that you’ll qualify for considerable compensation. Don’t forget to fill out our form to get our free Financial Compensation Packet, filled with information on the experienced asbestos and mesothelioma attorneys in your area. If you have questions or need additional assistance, contact us at 800-793-4540.